IL105287A - פפטידים עם שינויים בסיומת החנקן, בעלי פעילות ברדיקינין אנטוגוניסטית,תהליך להכנתם ומוצרי רוקחות המכילים אותם - Google Patents

פפטידים עם שינויים בסיומת החנקן, בעלי פעילות ברדיקינין אנטוגוניסטית,תהליך להכנתם ומוצרי רוקחות המכילים אותם

Info

Publication number
IL105287A
IL105287A IL10528793A IL10528793A IL105287A IL 105287 A IL105287 A IL 105287A IL 10528793 A IL10528793 A IL 10528793A IL 10528793 A IL10528793 A IL 10528793A IL 105287 A IL105287 A IL 105287A
Authority
IL
Israel
Prior art keywords
arg
formula
peptide
direct linkage
radical
Prior art date
Application number
IL10528793A
Other languages
English (en)
Other versions
IL105287A0 (en
Original Assignee
Hoechst Aktiengeselleschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengeselleschaft filed Critical Hoechst Aktiengeselleschaft
Publication of IL105287A0 publication Critical patent/IL105287A0/xx
Publication of IL105287A publication Critical patent/IL105287A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
IL10528793A 1992-04-04 1993-04-02 פפטידים עם שינויים בסיומת החנקן, בעלי פעילות ברדיקינין אנטוגוניסטית,תהליך להכנתם ומוצרי רוקחות המכילים אותם IL105287A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4211406 1992-04-04

Publications (2)

Publication Number Publication Date
IL105287A0 IL105287A0 (en) 1993-08-18
IL105287A true IL105287A (he) 1999-12-31

Family

ID=6456125

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10528793A IL105287A (he) 1992-04-04 1993-04-02 פפטידים עם שינויים בסיומת החנקן, בעלי פעילות ברדיקינין אנטוגוניסטית,תהליך להכנתם ומוצרי רוקחות המכילים אותם

Country Status (25)

Country Link
US (1) US5597803A (he)
EP (1) EP0564972B1 (he)
JP (1) JP3426639B2 (he)
KR (1) KR100273825B1 (he)
CN (1) CN1040330C (he)
AT (1) ATE183197T1 (he)
AU (1) AU667707B2 (he)
BR (1) BR9301436A (he)
CA (1) CA2093305A1 (he)
CZ (1) CZ285698B6 (he)
DE (1) DE59309726D1 (he)
DK (1) DK0564972T3 (he)
ES (1) ES2136626T3 (he)
FI (1) FI931474A (he)
GR (1) GR3031543T3 (he)
HU (1) HU217613B (he)
IL (1) IL105287A (he)
MX (1) MX9301926A (he)
NO (1) NO311941B1 (he)
NZ (1) NZ247317A (he)
PL (1) PL175901B1 (he)
RU (1) RU2109747C1 (he)
SK (1) SK281970B6 (he)
TW (1) TW258739B (he)
ZA (1) ZA932399B (he)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024422A1 (en) * 1994-03-09 1995-09-14 Cortech, Inc. Bradykinin antagonist peptides incorporating n-substituted glycines
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
FR2790260B1 (fr) 1999-02-26 2001-05-04 Fournier Ind & Sante Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US6699486B1 (en) 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
US20040248809A1 (en) * 2003-02-07 2004-12-09 Aventis Pharma Deutschland Gmbh Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
US20210238230A1 (en) 2018-04-20 2021-08-05 Fresenius Kabi Ipsum S.R.L. A method for production of high purity icatibant

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210584A (en) * 1979-01-15 1980-07-01 Eli Lilly And Company Vindesine synthesis
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina

Also Published As

Publication number Publication date
EP0564972A3 (en) 1994-10-05
CN1040330C (zh) 1998-10-21
JPH0665289A (ja) 1994-03-08
EP0564972B1 (de) 1999-08-11
ES2136626T3 (es) 1999-12-01
FI931474A (fi) 1993-10-05
CZ285698B6 (cs) 1999-10-13
NO931287L (no) 1993-10-05
NO311941B1 (no) 2002-02-18
SK28993A3 (en) 1993-11-10
EP0564972A2 (de) 1993-10-13
ZA932399B (en) 1993-10-19
CN1077202A (zh) 1993-10-13
BR9301436A (pt) 1993-10-13
HUT64775A (en) 1994-02-28
NO931287D0 (no) 1993-04-02
NZ247317A (en) 1995-03-28
ATE183197T1 (de) 1999-08-15
KR930021656A (ko) 1993-11-22
GR3031543T3 (en) 2000-01-31
PL175901B1 (pl) 1999-03-31
IL105287A0 (en) 1993-08-18
AU3565193A (en) 1993-10-07
TW258739B (he) 1995-10-01
SK281970B6 (sk) 2001-09-11
KR100273825B1 (ko) 2000-12-15
DK0564972T3 (da) 2000-01-24
CA2093305A1 (en) 1993-10-05
HU9300972D0 (en) 1993-06-28
CZ57293A3 (en) 1994-03-16
AU667707B2 (en) 1996-04-04
US5597803A (en) 1997-01-28
DE59309726D1 (de) 1999-09-16
FI931474A0 (fi) 1993-04-01
HU217613B (hu) 2000-03-28
RU2109747C1 (ru) 1998-04-27
MX9301926A (es) 1993-10-01
JP3426639B2 (ja) 2003-07-14
PL298362A1 (en) 1993-10-18

Similar Documents

Publication Publication Date Title
KR0139632B1 (ko) 브라디키닌 길항 작용을 갖는 펩티드
CA2023194C (en) Peptides having bradykinin antagonist action
US5597803A (en) Bradykinin peptides with modifications at the N terminus
US5648333A (en) Peptides having bradykinin antagonist action
JP2552402B2 (ja) ブラジキニン拮抗作用を有するペプチド
CN1034416Y (zh) 有舒缓激肽拮抗作用的肽的制备方法
RU2083586C1 (ru) Пептиды или их физиологически приемлемые соли
LT3872B (en) Novel peptides and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
HK Corrigendum

Free format text: CORRECT ADDRESS FOR SERVICE TO- EITAN, PEARL, LATZER AND COHEN-ZEDEK 7 SHENKAR ST., HERZLIYA

KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees